Systematic review and meta-analysis reveals challenges in estimating PFAS half-lives in humans, highlighting the need to account for ongoing exposure and individual traits.
Despite the efforts made to better understand PFAS toxicokinetics, further studies are needed to identify important characteristics of these persistent chemicals. Biomonitoring studies should focus on persistent and unaccounted sources of exposure to PFAS and on individual characteristics potentially determining half-life, to ensure accurate estimates.
No takes yet. Share an insight, caveat, or question.
Rosato et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: